From mutant mice to "vascular permeability therapy" in cavernous angiomas?

Neurosurgery. 2009 May;64(5):N10. doi: 10.1227/01.neu.0000351421.45333.09.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / therapy
  • Carrier Proteins / genetics
  • Disease Models, Animal
  • Hemangioma, Cavernous* / genetics
  • Hemangioma, Cavernous* / therapy
  • Humans
  • Mice
  • Mice, Mutant Strains

Substances

  • CCM2 protein, human
  • Carrier Proteins